510(k) Report

510(k) · Cleared

Cleared

NC PTA Balloon Dilatation Catheter

K254212510(k) TraditionalCleared Sep 16, 2026261-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Kossel Medtech (Suzhou) Co., Ltd. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Sep 16, 2026 as substantially equivalent to K181323 (C.R. Bard, Inc., 2018) after a 261-day review. Its family tree reaches back 7 generations to 1993.

Decided
Sep 16, 2026
Review
261 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K933483 (1993). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK933483 Opti-Plast 5F Pta CathetersVas-Cath, Inc. · 1993
  2. 6 generations backK973013 Opti-Plast (Centurion) 5.5F Angioplasty CatheterVas-Cath, Inc. · 1998
  3. 5 generations backK040243 Bard Atlas Pta Balloon Dilatation CatheterC.R. Bard, Inc. · 2004
  4. 4 generations backK052236 Bard Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc. · 2005
  5. 3 generations backK120971 Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc. · 2012
  6. 2 generations backK122984 Atlas Gold Pta Dilatation CatheterC.R. Bard, Inc. · 2012
  7. 1 generation backK181323 Atlas Gold PTA Dilatation CatheterC.R. Bard, Inc. · 2018
  8. This deviceK254212 NC PTA Balloon Dilatation CatheterKossel Medtech (Suzhou) Co., Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K933483Opti-Plast 5F Pta CathetersVas-Cath, Inc.1993—
−6K973013Opti-Plast (Centurion) 5.5F Angioplasty CatheterVas-Cath, Inc.1998—
−5K040243Bard Atlas Pta Balloon Dilatation CatheterC.R. Bard, Inc.2004—
−4K052236Bard Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc.2005—
−3K120971Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc.2012—
−2K122984Atlas Gold Pta Dilatation CatheterC.R. Bard, Inc.2012—
−1K181323Atlas Gold PTA Dilatation CatheterC.R. Bard, Inc.2018—
0 (this device)K254212NC PTA Balloon Dilatation CatheterKossel Medtech (Suzhou) Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
200210
201110
FIG. 1 — Lineage of K254212, 1993–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181323Atlas Gold PTA Dilatation Catheter
Summary page 4
…ansluminal Name: Regulation Number: 21 CFR 870.1250 Product Code: LIT Regulatory Class: Class II Predicate Device: Atlas® Gold PTA Dilatation Catheter (K181323) Reference device: MAXI LD PTA Dilatation Catheter (K96300) Device Description: The NC PTA Balloon Dilatation Catheter is…
C.R. Bard, Inc.2018—
†K096300MAXI LD PTA Dilatation Catheter—

Also cleared against K181323: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 4 companies; a new generation was cleared every 5.7 years on median.
  • None of the 10 ancestors has a recall.
  • 1 other device also cites its predicate K181323.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The NC PTA Dilatation Catheter is indicated for use in Percutaneous Transluminal Angioplasty of the peripheral vasculature, including the iliac arteries and iliac and femoral veins, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K254212: NC PTA Balloon Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K254212

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026